Table 5.
Detection of anticipated aberrations across platforms for the 6 tumour samples
| T1975 | T2701 | T2704 | T2706 | T2707 | T2714 | |
|---|---|---|---|---|---|---|
| Gain 8p | possibly 8q (all) | also 8q (all) | none | none | none | none, but gain on 8q (all but Nimb) |
| Gain 1q | all | all | all | none | all but Nimb | |
| Loss 16q | partial (all) | and gain 16p (all) | none | and gain 16p (all) | none | none |
| Amp 8q24 | all | all | none | none | none | all but Nimb |
| Amp 11q13 | none | all | none | none | none | none |
| Amp 17q12 | none | none | none | none | none | all |
| Amp 20q13 | all | Affy and Agil | none | none | none | none |
| Del 13q14 | all | all | none | none | none | none |
| Del 9p21 | all but Nimb | all | none | none | none | none |
| Del 17p13 | none | all | all | none | none | all |
The detection of anticipated aberrations in each of the 6 tumour samples is reported for each platform.